ACHC - Company ID 0001520697
The table below shows Acadia Healthcare Company, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Revenue | $828.80M | - | $851.57M | $869.23M | $770.50M | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Acadia Healthcare Company, Inc. reported annual revenue of $3.31B for fiscal year 2025. That is up 5.0% from $3.15B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.81B (FY 2016) to $3.31B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Operating income | - | - | - | - | - | - |
| Income tax | $6.50M | - | $1.67M | $12.07M | $4.40M | - |
| Net income | $4.11M | -$1.18B | $36.25M | $30.13M | $8.37M | $32.62M |
| EPS (diluted) | $0.05 | - | $0.40 | $0.33 | $0.09 | - |